Tumor infiltration by M2-like CD163+ CD33+ PD-L1+ macrophages was found in tumor biopsies from all non small cell lung cancer (NSCLC) patients exhibiting hyperprogression. Here, CD163 is linked to non-small cell lung carcinoma.